furazolidone has been researched along with Cardiovascular Stroke in 2 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czarnecki, CM | 1 |
| Evanson, OA | 1 |
| Powers, MD | 1 |
| Grahn, DA | 1 |
| Good, AL | 1 |
| Smith, HJ | 1 |
| Nuttall, A | 1 |
2 other studies available for furazolidone and Cardiovascular Stroke
| Article | Year |
|---|---|
Effect of furazolidone on plasma enzyme and protein levels in turkey poults.
Topics: Animals; Aspartate Aminotransferases; Blood Proteins; Creatine Kinase; Furazolidone; L-Lactate Dehyd | 1981 |
Experimental models of heart failure.
Topics: Animals; Barbiturates; Blood Pressure; Blood Volume; Cardiomegaly; Cardiomyopathy, Dilated; Cats; Cr | 1985 |